Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD.

Clinical trial NCT06271330 · RECRUITING

Trial details

NCT number: NCT06271330
Sponsor: Nantes University Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Age-related Macular Degeneration

Start date: 2024-04-01
Primary completion: 2025-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.